Shriram Revankar Sells 3,000 Shares of Dolby Laboratories (NYSE:DLB) Stock

Key Points

  • Insider sale: Dolby Laboratories SVP Shriram Revankar sold 3,000 shares on May 15 at an average price of $54.90, totaling $164,700. After the sale, he still held 80,603 shares, a 3.59% reduction in his position.
  • Recent performance: Dolby beat its latest quarterly earnings expectations, reporting $1.37 EPS versus $1.31 expected and revenue of $395.63 million versus $385.80 million estimated. Revenue rose 7% year over year, and the company reaffirmed upbeat FY2026 and Q3 2026 EPS guidance.
  • Dividend and analyst view: Dolby declared a quarterly dividend of $0.36 per share, or $1.44 annually, for a 2.7% yield. Analysts currently rate the stock a Moderate Buy with an average price target of $90.75.

Dolby Laboratories (NYSE:DLB - Get Free Report) SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the transaction, the senior vice president directly owned 80,603 shares of the company's stock, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Dolby Laboratories Price Performance

DLB opened at $53.32 on Wednesday. The stock has a 50-day moving average price of $60.64 and a 200-day moving average price of $63.59. The firm has a market cap of $5.04 billion, a PE ratio of 21.08 and a beta of 0.86. Dolby Laboratories has a 1 year low of $53.20 and a 1 year high of $77.14.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.Dolby Laboratories's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, sell-side analysts anticipate that Dolby Laboratories will post 3.22 EPS for the current year.

Dolby Laboratories Dividend Announcement




The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories's payout ratio is currently 56.92%.

Wall Street Analysts Forecast Growth

DLB has been the subject of several research analyst reports. Wall Street Zen downgraded Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, January 31st. Rosenblatt Securities reiterated a "buy" rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, January 30th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Dolby Laboratories in a report on Friday, March 27th. Finally, Barrington Research reiterated an "outperform" rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Dolby Laboratories currently has an average rating of "Moderate Buy" and an average target price of $90.75.

View Our Latest Analysis on Dolby Laboratories

Institutional Investors Weigh In On Dolby Laboratories

A number of large investors have recently made changes to their positions in the company. Edgestream Partners L.P. grew its stake in shares of Dolby Laboratories by 232.8% during the 1st quarter. Edgestream Partners L.P. now owns 22,376 shares of the electronics maker's stock valued at $1,344,000 after purchasing an additional 15,652 shares during the period. Amundi bought a new stake in shares of Dolby Laboratories during the 1st quarter valued at about $280,000. California State Teachers Retirement System grew its stake in shares of Dolby Laboratories by 24.5% during the 1st quarter. California State Teachers Retirement System now owns 72,518 shares of the electronics maker's stock valued at $4,355,000 after purchasing an additional 14,270 shares during the period. Quantinno Capital Management LP grew its stake in shares of Dolby Laboratories by 23.0% during the 1st quarter. Quantinno Capital Management LP now owns 58,316 shares of the electronics maker's stock valued at $3,503,000 after purchasing an additional 10,887 shares during the period. Finally, Entropy Technologies LP bought a new stake in shares of Dolby Laboratories during the 1st quarter valued at about $1,674,000. 58.56% of the stock is currently owned by institutional investors.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Dolby Laboratories?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Dolby Laboratories and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles